Lifevantage Statistics
NASDAQ: LFVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.00-0.04 (-0.66%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Lifevantage by the numbers
Lifevantage has a market capitalization of $75.5 million based on 12.59M shares outstanding. Its trailing P/E ratio is 15.0, and its forward P/E is 15.5. The stock trades 6.1% below its 50-day average and 1.4% above its 200-day average.
Average daily trading volume is 61.76K shares, or about $370,530 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LFVN valuation vs. peer median
| Metric | LFVN | Peer median | Difference |
|---|---|---|---|
| Market cap | $75.54M | $76.47M | -1% |
| Avg. volume | 61.76K | 514.02K | -88% |
Peer median across 8 companies: ONCY, RFL, INCR, PDSB, NTHI, HRTX, GANX, MAIA.
Valuation
- Market cap
- $75.54M
- P/E (TTM)
- 15.00
- Forward P/E
- 15.52
- EPS (TTM)
- $0.40
- Shares outstanding
- 12.59M
Price and trading
- Previous close
- 6.04
- Open
- 6.00
- Day range
- 5.97 – 6.16
- 52-week range
- 3.90 – 11.71
- 52-week change
- -35.14%
- Beta
- —
- Volume
- 24.95K
- Average volume
- 61.76K
Dividends and events
- Annual dividend
- $0.185
- Dividend yield
- 3.08%
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 75.54M
- Pe
- 15.00
- Forward Pe
- 15.52
- Eps
- 0.40
- Dividend Yield
- 3.33%
- Dividend Rate
- 0.19
- Week52 High
- 11.71
- Week52 Low
- 3.90
- Avg Volume
- 61,755.00
- Shares Outstanding
- 12.59M
- Ma50
- 6.39
- Ma200
- 5.91
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -48.76%
- Pct From52w Low
- 53.85%